Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9480	Companies
185564	Keywords
117971	Articles
99400	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 11/22/2024 at 14:45, 1 year ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Jaguar Health, Inc. announces extension of FDA approval for Canalevia®-CA1 for chemotherapy-induced diarrhea in dogs, seeks partner for NP300 development at Pet Connect conference

Jaguar Health Diarrhea Veterinary NP300 Canalevia®-CA1
BRIEF

published on 11/19/2024 at 15:35, 1 year ago

Napo Therapeutics Awarded "Best Pharmaceuticals Innovator of the Year - Europe"

Crofelemer Awards Rare Diseases Napo Therapeutics Innovative Pharmaceuticals
BRIEF

published on 11/19/2024 at 15:35, 1 year ago

Napo Therapeutics élu « Meilleur innovateur pharmaceutique de l'année - Europe »

Crofelemer Récompenses Maladies Rares Napo Thérapeutique Produits Pharmaceutiques Innovants
PRESS RELEASE

published on 11/19/2024 at 15:30, 1 year ago

Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year - Europe”
Jaguar Health's Napo Therapeutics awarded 'Best Pharmaceuticals Innovator of the Year - Europe' for expanding access to crofelemer in Europe for orphan and rare diseases. Partnering with Jaguar and Napo Pharmaceuticals for clinical studies

Crofelemer Jaguar Health Rare Diseases Orphan Diseases Napo Therapeutics
BRIEF

published on 11/13/2024 at 14:05, 1 year ago

Jaguar Health Reports Strong Q3 2024 Financial Performance

Financial Results Crofelemer Jaguar Health Q3 2024 Cancer Supportive Care
BRIEF

published on 11/13/2024 at 14:05, 1 year ago

Jaguar Health annonce de solides résultats financiers au troisième trimestre 2024

Résultats Financiers Crofelemer Santé Jaguar 3e Trimestre 2024 Soins De Soutien Aux Personnes Atteintes De Cancer
PRESS RELEASE

published on 11/13/2024 at 14:00, 1 year ago

Jaguar Health Reports Third Quarter 2024 Financial Results
Jaguar Health, Inc. reports a 14% revenue increase in Q3 2024, introduces Gelclair commercial launch. Initiates Phase 2 trials and IIT studies. Hosts investor webcast on November 13

Revenue Increase Jaguar Health Q3 2024 Phase 2 Trials Gelclair
BRIEF

published on 11/11/2024 at 14:35, 1 year ago

Jaguar Health to Discuss Q3 2024 Financials in Upcoming Investor Webcast

Napo Pharmaceuticals Crofelemer Investor Webcast Jaguar Health Q3 Financials
BRIEF

published on 11/11/2024 at 14:35, 1 year ago

Jaguar Health discutera des résultats financiers du troisième trimestre 2024 lors d'un prochain webcast destiné aux investisseurs

Crofelemer Santé Jaguar Napo Pharmaceutique Résultats Financiers Du Troisième Trimestre Webcast Pour Les Investisseurs
PRESS RELEASE

published on 11/11/2024 at 14:30, 1 year ago

Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates
Jaguar Health, Inc. (NASDAQ:JAGX) to conduct investor webcast on November 13, 2024 at 8:30 a.m. Eastern to review Q3 2024 financials and provide corporate updates

Investor Webcast Jaguar Health Corporate Updates Q3 Financials NASDAQ:JAGX

Accesswire

Published on 12/06/2025 at 02:00, 9 hours 39 minutes ago

Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 10 hours 24 minutes ago

Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 11 hours 14 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 11 hours 39 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 12 hours 9 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 13 hours 23 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 13 hours 27 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 16 hours 41 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 17 hours 13 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 17 hours 24 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 23:00, 12 hours 39 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 12 hours 39 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 12 hours 39 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 12 hours 39 minutes ago

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 18 hours 21 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible

View all LES ECHOS COMFI WIRE